Research Papers

25 of 323 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
An In Silico Platform to Predict Cardiotoxicity Risk of Anti-tumor Drug Combination with hiPSC-CMs Based In Vitro Study.
Sang L; Zhou Z; Luo S; Zhang Y; Qian H; Zhou Y; He H; Hao K.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems.
Luo S; Zhang B.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assay…
Butala-Flores E; Nguyen T; Selvan N; Armstrong L; Miller M; Kamen L; Lester T; Wernyj R; Khanna R; McNally J; Hays A.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practical Advice on Scientific Design of Freeze-Drying Process: 2023 Update.
Tchessalov S; Maglio V; Kazarin P; Alexeenko A; Bhatnagar B; Sahni E; Shalaev E.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System Parameters.
Pepin XJH; Grant I; Wood JM.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differ…
Bällgren F; Hammarlund-Udenaes M; Loryan I.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OA…
Huh Y; Plotka A; Wei H; Kaplan J; Raha N; Towner J; Purohit VS; Dowty ME; Wolk R; Vourvahis M; King-Ahmad A; Mathialagan S; West MA; Lazzaro S; Ryu S; Rodrigues AD.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Challenges and Opportunities for Celecoxib Repurposing.
Bąk U; Krupa A.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A Physiology-Based Mathematical Model to Understand Drug Delivery from Contact Lenses to the Back of the Eye.
Toffoletto N; Saramago B; Serro AP; Chauhan A.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening an…
Yu YB; Briggs KT; Taraban MB.
Pharm Res (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.
Shi K; Li M.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections.
Loo CY; Lee WH; Zhou QT.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mechanism of Insoluble Aggregate Formation in a Reconstituted Solution of Spray-Dried Protein Powder.
Tao Y; Chen Y; Howard W; Ibrahim M; Patel SM; McMahon WP; Kim YJ; Delmar JA; Davis D.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of the Adsorbed Vaccine Formulations Using Water Proton Nuclear Magnetic Resonance-Comparison with Optical Ana…
Taraban MB; Ndung'u T; Karki P; Li K; Fung G; Kirkitadze M; Yu YB.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impostor Phenomenon and Grit as Predictors of Job Satisfaction in Female Pharmacy Faculty.
Macias-Moriarity LZ; Sinclair SM; Walker D; Purnell M.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of Escherichia coli-derived Recombinant Human Bone Morphogenic Protein-2 on Fertilization and Early Embryoni…
Kim NH; Min SK; Lee MW; Kang SH.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Trends in Light and Temperature Sensitivity Recommendations among Licensed Biotechnology Drug Products.
Kim JJ; Pritts JD; Ngo M; Estoll CR; Rao VA.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Zinc Oxide Nanoparticles Promise Anticancer and Antibacterial Activity in Ovarian Cancer.
Mousa AB; Moawad R; Abdallah Y; Abdel-Rasheed M; Zaher AMA.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of Different Saccharides on the In-Process Stability of a Protein Drug During Evaporative Drying: From Sessile D…
Dieplinger J; Pinto JT; Dekner M; Brachtl G; Paudel A.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Reference Standards to Support Quality of Synthetic Peptide Therapeutics.
McCarthy D; Han Y; Carrick K; Schmidt D; Workman W; Matejtschuk P; Duru C; Atouf F.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats.
Gao X; Sheng YH; Yu S; Li J; Rosa R; Girgis S; Guo T; Brunetti L; Kagan L.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuber…
Shao Z; Chow MYT; Chow SF; Lam JKW.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
miRNA Signature of Urine Extracellular Vesicles Shows the Involvement of Inflammatory and Apoptotic Processes in Diabet…
Zapała B; Kamińska A; Piwowar M; Paziewska A; Gala-Błądzińska A; Stępień EŁ.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of Aerosol Deposition Between a Cynomolgus Macaque and a 3D Printed Cast Model of the Animal.
Creppy J; Cabrera M; Kahlaoui N; Pardessus J; Lemaitre J; Naninck T; Delache B; Roseau G; Ducancel F; Vecellio L.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery.
Sun D; Lu ZR.
Pharm Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared